Clinical Trial Update: Evaluation Of The Impact Of A Call Center In Management Of Metastatic And/Or Advanced Renal Cell Carcinoma Patients Treated With Sunitinib (Sutent) In First Line

View source ↗

Summary

Clinical trial evaluating the impact of a call center on management of metastatic/advanced renal cell carcinoma patients treated with sunitinib in first-line; s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Sutent (sunitinib)

Snippet

Sponsor: Pfizer | Conditions: Metastatic/Advanced Renal Cell Carcinoma | Status: COMPLETED | Results posted: 2019-10-24